COVID-19 VA UNING ASORATLARI

Xegay Lyubov Nikolaevna; Yusupova  Shaxnoza  Kadirjanovna; ABDURAXIMOV ABDUXALIM XOLIDDIN O‘G‘LI

doi:10.24411/2181-0443/2021-10125

621

COVID-19 yurak, o'pka, miya, buyraklar, qon tomirlari va insonning boshqa hayotiy muhim sistema va organlarida jiddiy asoratlarni keltirib chiqarishi mumkin. COVID-19 nafas yo'llari infektsiyasi bo'lsa-da, shifokorlar bu ko'p tizimli kasallik ekanligini tan olishadi, boshqacha aytganda, u har qanday organga ta'sir qilishi mumkin. Va barcha shifokorlar uning oqibatlariga duch kelishadi, pulmonologlardan trixologlar va psixiatrlargacha. Ko'pgina bemorlar, hatto COVID-19 dan tuzalib ketganidan keyin ham sog'lig'idan shikoyat qiladilar. Shikoyatlar juda farq qiladi - soch to'kilishidan trombozga qadar. Shunday qilib, ushbu maqolada biz koronavirus bilan kasallangandan keyingi asoratlarni muhokama qilamiz.

Журнал номиRE-HEALTH
Нашр номи4 (12)-2021
Кўришлар сони 621

Internet ҳавола https://cyberleninka.ru/journal/n/re-health-journal?i=1087121

DOI10.24411/2181-0443/2021-10125

UzSCI тизимида яратилган сана 12-12-2021

Ўқишлар сони 616

Нашр санаси 12-12-2021

Мақола тилиO'zbek

Саҳифалар сони64-77

Калит сўзлар

miya

COVID-19

Yurak

infektsiya

o'pka

buyraklar

qon tomirlar

pulmonolog

trixolog

psixiatr

Русский

COVID-19 способен вызывать тяжелые осложнения со стороны сердца, легких, мозга, почек, сосудов и других жизненно важных систем и органов человека. Хотя COVID-19 и относится к респираторным инфекциям, врачи признают: заболевание это мультисистемное, проще говоря, оно может задеть любой орган. И сталкиваются с его последствиями все врачи — от очевидных пульмонологов до трихологов и психиатров. Многие пациенты даже после выздоровления от COVID-19 жалуются на здоровье. Жалобы самые разные — от выпадения волос до тромбоза. Таким образом, в этой статье мы обсуждаем осложнения после заражения коронавирусом

Калит сўзлар

легкие

сердце

COVID-19

Ўзбек

COVID-19 yurak, o'pka, miya, buyraklar, qon tomirlari va insonning boshqa hayotiy muhim sistema va organlarida jiddiy asoratlarni keltirib chiqarishi mumkin. COVID-19 nafas yo'llari infektsiyasi bo'lsa-da, shifokorlar bu ko'p tizimli kasallik ekanligini tan olishadi, boshqacha aytganda, u har qanday organga ta'sir qilishi mumkin. Va barcha shifokorlar uning oqibatlariga duch kelishadi, pulmonologlardan trixologlar va psixiatrlargacha. Ko'pgina bemorlar, hatto COVID-19 dan tuzalib ketganidan keyin ham sog'lig'idan shikoyat qiladilar. Shikoyatlar juda farq qiladi - soch to'kilishidan trombozga qadar. Shunday qilib, ushbu maqolada biz koronavirus bilan kasallangandan keyingi asoratlarni muhokama qilamiz.

Калит сўзлар

miya

COVID-19

Yurak

infektsiya

o'pka

buyraklar

qon tomirlar

pulmonolog

trixolog

psixiatr

English

COVID-19 can cause serious complications in the heart, lungs, brain, kidneys, blood vessels, and other vital human systems and organs. Although COVID-19 is a respiratory infection, doctors recognize that it is a multi-systemic disease, in other words, it can affect any organ. And all doctors face its consequences, from pulmonologists to trichologists and psychiatrists. Many patients complain of poor health even after recovery from COVID-19. Complaints vary greatly - from hair loss to thrombosis. Thus, in this article, we discuss postcoronavirus complications.

Калит сўзлар

infection

blood vessels

heart

lungs

brain

COVID-19

kidneys

pulmonologist

trichologist

psychiatrist

№ Муаллифнинг исми Лавозими Ташкилот номи

1 Xegay L.N. . Андижанский государственный медицинский институт Ташкентская медицинская академия

2 Yusupova S.K. . Андижанский государственный медицинский институт Ташкентская медицинская академия

3 ABDURAXIMOV A.X. autor ASMI

№ Ҳавола номи

1 1. Qi F., Qian S., Zhang S., Zhang Z. Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses. Biochem. Biophys. Res. Commun. 2020;526(1):135–40. DOI: 10.1016/j.bbrc.2020.03.044.

2 2. Ortega J.T., Serrano M.L., Pujol F.H., Rangel H.R. Role of changes in SARS-CoV-2 spike protein in the interaction with the human ACE2 receptor: An in silico analysis. EXCLI J. 2020;19:410–7. DOI: 10.17179/excli2020-1167.

3 3. Wang K., Chen W., Zhou Y-S., Lian J-Q., Zhang Z., Du P. et al. SARS-CoV-2 invades host cells via a novel route: CD147-spike protein. Bio. Rxiv. The prep

4 4. Yu F., Du L., Ojcius D.M., Pan C., Jiang S. Measures for diagnosing and treating infections by a novelмcoronavirus responsible for a pneumonia outbreak originating in Wuhan, China. Microbes. Infect. 2020;22(2):74–9. DOI: 10.1016/j.micinf.2020.01.003.

5 5. Li B., Yang J., Zhao F. et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China // Clin. Res. Cardiol. ‒ 2020. ‒ Vol. 109, № 5. ‒ P. 531‒538. doi: 10.1007/s00392-020-01626-9.

6 6. Zhu H., Rhee J.W., Cheng P. et al. Cardiovascular complications in patients with COVID-19: consequences of viral toxicities and host immune response. Curr. Cardiol. Rep., 2020, vol. 22, no. 5, pp. 32, doi: 10.1007/s11886-020-01292-3.

7 7. Zhu H., Rhee J.W., Cheng P. et al. Cardiovascular complications in patients with COVID-19: consequences of viral toxicities and host immune response. Curr. Cardiol. Rep., 2020, vol. 22, no. 5, pp. 32, doi: 10.1007/s11886-020-01292-3.

8 8. Williams B., Zhang Y. Hypertension, rennin-angiotensin-aldosterone system inhibition, and COVID-19. Lancet, 2020, May 18. doi:10.1016/ s0140-6736(20)31131-4.

9 9. Ferrario C.M., Jessup J., Chappell M.C. et al. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation, 2005, vol. 111,

10 10. The official website of the American College of Cardiology. https://www.acc. org/latestin-cardiology/articles/2020/03/17/08/59/hfsa-acc-aha-statement-ad dresses-concerns-reusing-raas-antagonists-in-covid-19.

11 11. The official website of the European Society of Cardiology. https://www.escardio. org/Councils/Council-on-Hypertension-(CHT)/News/position-statement-ofthe-esc-councilon-hypertension-on-ace-inhibitors-and-ang.

12 12. The official website of the Russian Cardiology Society. https://scardio. ru/news/novosti_obschestva/lechenie_iapf_ili_bra_vo_vremya_pandemii_ covid19/

13 13. de Abajo F. J., Rodríguez-Martín S., Lerma V. et al. Use of renninangiotensin-aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study // Lancet. ‒ 2020. ‒ May 14. ‒ Р. 1705‒1714. DOI: 10.1016/S0140-6736(20)31030-8. PMID: 32416785

14 14. Gurwitz D. Angiotensin receptor blokers as tentative SARS-CoV-2. Therapeutic Drug. Dev. Res., 2020, Mar 4; 10.1002/ddr.21656. doi: 10.1002/ddr.21656. URL: researchgate.net.

15 15. de Abajo F.J., Rodríguez-Martín S., Lerma V. et al. Use of rennin-angiotensinaldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study. Lanc

16 16. Shi S., Qin M., Shen B. et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol., 2020, vol. 25, pp. e200950. doi: 10.1001/jamacardio.2020.0950.

17 17. Zhou F., Yu T., Du R. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet, 2020, vol. 395 (10229), pp. 1054‒1062. doi: 10.1016/S0140-6736(20)30566-3.

18 18. И. А. Козлов, И. Н. Тюрин. Сердечно-сосудистые осложнения COVID-19. doi.org/10.21292/2078-5658-2020-17-4-14-22.

19 19. Елена Гричук — заведующая кардиологическим отделением, кандидат медицинских наук. 74.ru/text/health/2021/10/08/70180778/.

20 20. Самсонова М.В., Михалева Л.М., Зайратьянц О.В., Варясин В.В., Быканова А.В., Мишнев О.Д., Березовский Ю.С., Тишкевич О.А., Гомзикова Е.А., Черняев А.Л., Хованская Т.Н. Патология легких при COVID-19 в Москве. Архив патологии. 2020;82(4):32-40. https://doi.org/10.17116/patol20208204132

21 21. Цинзерлинг А.В. Этиология и патологическая анатомия острых респираторных инфекций. Л.: Медицина; 1977. Tsinzerling AV. Etiologiya i patologicheskaya anatomiya ostrykh respiratornykh infektsii. L.: Meditsina; 1977. (In Russ.).

22 22. Petrosillo N, Viceconte G, Ergonul O, Ippolito G, Petersen E. COVID-19, SARS and MERS: are they closely related? Clin Microbiol Infect. 2020. pii: S1198-743X(20)30171-3. https://doi.org/10.1016/j.cmi.2020.03.026.

23 23. Wei Cao, Taisheng Li. COVID-19: towards understanding of pathogenesis. Cell Res. 2020;30(5):367-369. https://doi.org/10.1038/s41422-020-0327-4

24 24. Ling Lin, Lianfeng Lu, Wei Cao, Taisheng Li. Hypothesis for potential pathogenesis of SARS-CoV-2 infection — a review of immune changes in patients with viral pneumonia. Emerg Microbes Infect. 2020;9(1):727-732. https://doi.org/10.1080/22221751.2020.1746199.

25 25. Черняев А.Л., Зайратьянц О.В., Полянко Н.И., Келли Е.И., Рогов К.А., Михалева Л.М., Чарторижская Н.Н., Трусов А.Е., Самсонова М.В., Чучалин А.Г. Патологическая анатомия гриппа A/H1N1. Архив патологии. 2010;72(3):3-6. Chernyaev AL, Zairat’yants OV, Polyanko NI, Kelli EI, Rogov KA, Mikhaleva LM, Chartorizhskaya NN, Trusov AE, Samsonova MV, Chuchalin AG. Patologicheskaya anatomiya grippa A/H1N1. Archve of Pathology/Arkhiv patologii. 2010;72(3):3-6. (In Russ.).

26 26. Кунгурова В.В., Хасанянова С.В. К вопросу о мегакариоцитозе в сосудах микроциркуляции при различных видах наступления смерти (по данным судебногистологических исследований). Проблемы экспертизы в медицине. 2015;5(57-58): 15-

27 27. Yan Zhang, Meng Xiao, Shulan Zhang, Peng Xia, Wei Cao, Wei Jiang, Huan Chen, Xin Ding, Hua Zhao, Hongmin Zhang, Chunyao Wang, Jing Zhao., Xuefeng Sun, Ran Tian, et al. Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med. 2020;382(17):e38. https://doi.org/10.1056/NEJMc2007575.

28 28. Qian Z, Travanty EA, Oko L, et al. Innate immune response of human alveolar type II cells infected with severe acute respiratory syndrome-coronavirus. Am J Respir Cell Mol Biol. 2013;48:742-748. 29. Xu Zhe, Shi Lei

29 29. Xu Zhe, Shi Lei, Yijin Wang, Jiyuan Zhang, Lei Huang, Chao Zhang, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4): 420-422. https://doi.org/10.1016/S2213-2600(20)30076-X

30 30. COVID-19: ПОРАЖЕНИЕ НЕРВНОЙ СИСТЕМЫ И ПСИХОЛОГО-ПСИХИАТРИЧЕСКИЕ ОСЛОЖНЕНИЯ И.И. Шепелева, А.А. Чернышева, Е.М. Кирьянова, Л.И. Сальникова, О.И. Гурина.

31 31. Нечипоренко Н.А., Нечипоренко А.Н. Неотложные состояния в урологии. Минск. Вышэйшая школа, 2012; 400 с. [Nechiporenko N.A., Nechiporenko A.N. Emergencies in urology. Minsk. High school, 2012; 400 p. (In Russian)].

32 32. Болотов Ю.Н., Минаев С.В. Острые заболевания яичка у детей. Практическое руковод- ство. М.: ИНФРА-М, 2018; 107 с. [Bolotov Yu.N., Minaev S.V. Acute testicular disease in children. A practical guide. M.: INFRA-M, 2018; 107 p. (In Russian)]. https://doi.org/10.12737/2899.

33 33. Madaan S, Joniau S, Klockaerts K Costa M, Calleja R, Ball RY, Burgess N. Segmental testicular infarction. Conservative management is feasible and safe: part 2. Eur Urol 2008;53(3):656-8. https://doi.org/10.1016/j.eururo.2007.03.062.

34 34. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020;382(8):727-733. https://doi.org/10.1056/ NEJMoa2001017.

35 35. Ge H, Wang X, Yuan X, Xiao G, Wang C, Deng T, et al. The epidemiology and clinical information about COVID-19. Eur J Clin Microbiol Infect Dis. 2020;39(6):1011-1019. https://doi.org/10.1007/s10096-020-03874-z.

36 36. Sifuentes-Rodríguez E, Palacios-Reyes D. COVID-19: the outbreak caused by a new coronavirus. Bol Med Hosp Infant Mex 2020;77(2):47-53. https://doi.org/10.24875/BMHIM.20000039

37 37. Baloch S, Baloch MA, Zheng T, Pei X. The Coronavirus Disease 2019 (COVID-19) Pandemic. Tohoku J Exp Med 2020 Apr;250(4):271-278. https://doi.org/10.1620/tjem.250.271

38 38. Steinberg E, Balakrishna A, Habboushe J, Shawl A, Lee J. Calculated Decisions: COVID-19 Calculators During Extreme Resource-Limited Situations. Emerg Med Pract 2020;22(4 Suppl):CD1- CD5. 39. Малхасян В.А., К

39 39. Малхасян В.А., Касян Г.Р., Ходырева Л.А., Колонтарев К.Б., Говоров А.В., Васильев А.О., Пушкарь Д.Ю. Оказание стационарнои помощи пациентам урологического профиля в ̆ условиях пандемии коронаровируснои инфекции ̆ COVID-19. Экспериментальная и клиническая урология 2020;(1):4-11. [Malkhasyan V.A., Kasyan G.R., Khodyreva L.A., Kolontarev K.B., Govorov A.V., Vasiliev A.O., Pushkar D.Yu. providing inpatient care to urological patients in the context of the COVID-19 coronarovirus pandemic. Eksperimental'naya i klinicheskaya urologiya = Experimental and Clinical urology 2020;(1):4- 11. (In Russian)]. https://doi.org/10.29188/2222- 8543-2020-12-1-4-1.

40 40. Stensland KD, Morgan TM, Moinzadeh A, Lee CT, Briganti A, Catto J, Canes D. Considerations in the triage of urologic surgeries during the COVID-19 pandemic. Eur Urol 2020;77(6):663‐666. https://doi.org/10.1016/j.eururo.2020.03.027.

41 41. Un contagio su dieci tra medici e infermieri, in trincea con mascherine inadatte e pochi tampon. [Электронный ресурс]. URL: https://www.ilsole24ore.com/art/ un-contagio-dieci- %0Amedicie infermieritrinceamascherine-inadattee-pochi-tamponi-ADqwiFF

42 42. EAU Robotic Urology Section (ERUS) guidelines during COVID-19 emergency. [Электронный ресурс]. URL: https://uroweb.org/eau-robotic-urology-section-erus-guide-lines-duringc..., accessed on March 29, 2020.

43 43. Ficarra V, Novara G, Abrate A, Bartoletti R, Crestani A, de Nunzio C, et al. Urology practice during COVID-19 pandemic. Minerva Uro

44 44. Hollander J, Car B. Virtually Perfect? Telemedicine for Covid-19. N Engl J Med 2020(382)1679- 168. https://doi.org/10.1056/NEJMp2003539

45 45. Moazzami B, Razavi-Khorasani N, Dooghaie Moghadam A, Farokhi E, Rezaei N. COVID-19 and telemedicine: immediate action required for maintaining healthcare providers well-being. J Clin Virol 2020(126):104345. [Электронный ресурс]. URL: https://www.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd4029942. https://doi.org/10.1016/j.jcv.2020.10434513.

46 46. Для цитирования: Деревянко Т.И., Придчин С.В. Геморрагический инфаркт яичка как осложнение COVID-19 (SARS-CoV-2). Экспериментальная и клиническая урология 2021;14(2):70-72; https://doi.org/10.29188/2222-8543-2021-14-2-70-72.

47 47. А.Г. Алиев, А. Риахи, А.П. Середа, Е.В. Вебер, И.И. Шубняков, Р.М. Тихилов. Влияние пандемии Сovid-19 на госпитализацию пациентов после артропластики коленного и тазобедренного суставов. https://doi.org/10.18019/1028-4427-2021-27-5-570-577.

Кутилмоқда

№	Муаллифнинг исми	Лавозими	Ташкилот номи
1	Xegay L.N.	.	Андижанский государственный медицинский институт Ташкентская медицинская академия
2	Yusupova S.K.	.	Андижанский государственный медицинский институт Ташкентская медицинская академия
3	ABDURAXIMOV A.X.	autor	ASMI

№	Ҳавола номи
1	1. Qi F., Qian S., Zhang S., Zhang Z. Single cell RNA sequencing of 13 human tissues identify cell types and receptors of human coronaviruses. Biochem. Biophys. Res. Commun. 2020;526(1):135–40. DOI: 10.1016/j.bbrc.2020.03.044.
2	2. Ortega J.T., Serrano M.L., Pujol F.H., Rangel H.R. Role of changes in SARS-CoV-2 spike protein in the interaction with the human ACE2 receptor: An in silico analysis. EXCLI J. 2020;19:410–7. DOI: 10.17179/excli2020-1167.
3	3. Wang K., Chen W., Zhou Y-S., Lian J-Q., Zhang Z., Du P. et al. SARS-CoV-2 invades host cells via a novel route: CD147-spike protein. Bio. Rxiv. The prep
4	4. Yu F., Du L., Ojcius D.M., Pan C., Jiang S. Measures for diagnosing and treating infections by a novelмcoronavirus responsible for a pneumonia outbreak originating in Wuhan, China. Microbes. Infect. 2020;22(2):74–9. DOI: 10.1016/j.micinf.2020.01.003.
5	5. Li B., Yang J., Zhao F. et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China // Clin. Res. Cardiol. ‒ 2020. ‒ Vol. 109, № 5. ‒ P. 531‒538. doi: 10.1007/s00392-020-01626-9.
6	6. Zhu H., Rhee J.W., Cheng P. et al. Cardiovascular complications in patients with COVID-19: consequences of viral toxicities and host immune response. Curr. Cardiol. Rep., 2020, vol. 22, no. 5, pp. 32, doi: 10.1007/s11886-020-01292-3.
7	7. Zhu H., Rhee J.W., Cheng P. et al. Cardiovascular complications in patients with COVID-19: consequences of viral toxicities and host immune response. Curr. Cardiol. Rep., 2020, vol. 22, no. 5, pp. 32, doi: 10.1007/s11886-020-01292-3.
8	8. Williams B., Zhang Y. Hypertension, rennin-angiotensin-aldosterone system inhibition, and COVID-19. Lancet, 2020, May 18. doi:10.1016/ s0140-6736(20)31131-4.
9	9. Ferrario C.M., Jessup J., Chappell M.C. et al. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation, 2005, vol. 111,
10	10. The official website of the American College of Cardiology. https://www.acc. org/latestin-cardiology/articles/2020/03/17/08/59/hfsa-acc-aha-statement-ad dresses-concerns-reusing-raas-antagonists-in-covid-19.
11	11. The official website of the European Society of Cardiology. https://www.escardio. org/Councils/Council-on-Hypertension-(CHT)/News/position-statement-ofthe-esc-councilon-hypertension-on-ace-inhibitors-and-ang.
12	12. The official website of the Russian Cardiology Society. https://scardio. ru/news/novosti_obschestva/lechenie_iapf_ili_bra_vo_vremya_pandemii_ covid19/
13	13. de Abajo F. J., Rodríguez-Martín S., Lerma V. et al. Use of renninangiotensin-aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study // Lancet. ‒ 2020. ‒ May 14. ‒ Р. 1705‒1714. DOI: 10.1016/S0140-6736(20)31030-8. PMID: 32416785
14	14. Gurwitz D. Angiotensin receptor blokers as tentative SARS-CoV-2. Therapeutic Drug. Dev. Res., 2020, Mar 4; 10.1002/ddr.21656. doi: 10.1002/ddr.21656. URL: researchgate.net.
15	15. de Abajo F.J., Rodríguez-Martín S., Lerma V. et al. Use of rennin-angiotensinaldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study. Lanc
16	16. Shi S., Qin M., Shen B. et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol., 2020, vol. 25, pp. e200950. doi: 10.1001/jamacardio.2020.0950.
17	17. Zhou F., Yu T., Du R. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet, 2020, vol. 395 (10229), pp. 1054‒1062. doi: 10.1016/S0140-6736(20)30566-3.
18	18. И. А. Козлов, И. Н. Тюрин. Сердечно-сосудистые осложнения COVID-19. doi.org/10.21292/2078-5658-2020-17-4-14-22.
19	19. Елена Гричук — заведующая кардиологическим отделением, кандидат медицинских наук. 74.ru/text/health/2021/10/08/70180778/.
20	20. Самсонова М.В., Михалева Л.М., Зайратьянц О.В., Варясин В.В., Быканова А.В., Мишнев О.Д., Березовский Ю.С., Тишкевич О.А., Гомзикова Е.А., Черняев А.Л., Хованская Т.Н. Патология легких при COVID-19 в Москве. Архив патологии. 2020;82(4):32-40. https://doi.org/10.17116/patol20208204132
21	21. Цинзерлинг А.В. Этиология и патологическая анатомия острых респираторных инфекций. Л.: Медицина; 1977. Tsinzerling AV. Etiologiya i patologicheskaya anatomiya ostrykh respiratornykh infektsii. L.: Meditsina; 1977. (In Russ.).
22	22. Petrosillo N, Viceconte G, Ergonul O, Ippolito G, Petersen E. COVID-19, SARS and MERS: are they closely related? Clin Microbiol Infect. 2020. pii: S1198-743X(20)30171-3. https://doi.org/10.1016/j.cmi.2020.03.026.
23	23. Wei Cao, Taisheng Li. COVID-19: towards understanding of pathogenesis. Cell Res. 2020;30(5):367-369. https://doi.org/10.1038/s41422-020-0327-4
24	24. Ling Lin, Lianfeng Lu, Wei Cao, Taisheng Li. Hypothesis for potential pathogenesis of SARS-CoV-2 infection — a review of immune changes in patients with viral pneumonia. Emerg Microbes Infect. 2020;9(1):727-732. https://doi.org/10.1080/22221751.2020.1746199.
25	25. Черняев А.Л., Зайратьянц О.В., Полянко Н.И., Келли Е.И., Рогов К.А., Михалева Л.М., Чарторижская Н.Н., Трусов А.Е., Самсонова М.В., Чучалин А.Г. Патологическая анатомия гриппа A/H1N1. Архив патологии. 2010;72(3):3-6. Chernyaev AL, Zairat’yants OV, Polyanko NI, Kelli EI, Rogov KA, Mikhaleva LM, Chartorizhskaya NN, Trusov AE, Samsonova MV, Chuchalin AG. Patologicheskaya anatomiya grippa A/H1N1. Archve of Pathology/Arkhiv patologii. 2010;72(3):3-6. (In Russ.).
26	26. Кунгурова В.В., Хасанянова С.В. К вопросу о мегакариоцитозе в сосудах микроциркуляции при различных видах наступления смерти (по данным судебногистологических исследований). Проблемы экспертизы в медицине. 2015;5(57-58): 15-
27	27. Yan Zhang, Meng Xiao, Shulan Zhang, Peng Xia, Wei Cao, Wei Jiang, Huan Chen, Xin Ding, Hua Zhao, Hongmin Zhang, Chunyao Wang, Jing Zhao., Xuefeng Sun, Ran Tian, et al. Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med. 2020;382(17):e38. https://doi.org/10.1056/NEJMc2007575.
28	28. Qian Z, Travanty EA, Oko L, et al. Innate immune response of human alveolar type II cells infected with severe acute respiratory syndrome-coronavirus. Am J Respir Cell Mol Biol. 2013;48:742-748. 29. Xu Zhe, Shi Lei
29	29. Xu Zhe, Shi Lei, Yijin Wang, Jiyuan Zhang, Lei Huang, Chao Zhang, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4): 420-422. https://doi.org/10.1016/S2213-2600(20)30076-X
30	30. COVID-19: ПОРАЖЕНИЕ НЕРВНОЙ СИСТЕМЫ И ПСИХОЛОГО-ПСИХИАТРИЧЕСКИЕ ОСЛОЖНЕНИЯ И.И. Шепелева, А.А. Чернышева, Е.М. Кирьянова, Л.И. Сальникова, О.И. Гурина.
31	31. Нечипоренко Н.А., Нечипоренко А.Н. Неотложные состояния в урологии. Минск. Вышэйшая школа, 2012; 400 с. [Nechiporenko N.A., Nechiporenko A.N. Emergencies in urology. Minsk. High school, 2012; 400 p. (In Russian)].
32	32. Болотов Ю.Н., Минаев С.В. Острые заболевания яичка у детей. Практическое руковод- ство. М.: ИНФРА-М, 2018; 107 с. [Bolotov Yu.N., Minaev S.V. Acute testicular disease in children. A practical guide. M.: INFRA-M, 2018; 107 p. (In Russian)]. https://doi.org/10.12737/2899.
33	33. Madaan S, Joniau S, Klockaerts K Costa M, Calleja R, Ball RY, Burgess N. Segmental testicular infarction. Conservative management is feasible and safe: part 2. Eur Urol 2008;53(3):656-8. https://doi.org/10.1016/j.eururo.2007.03.062.
34	34. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med 2020;382(8):727-733. https://doi.org/10.1056/ NEJMoa2001017.
35	35. Ge H, Wang X, Yuan X, Xiao G, Wang C, Deng T, et al. The epidemiology and clinical information about COVID-19. Eur J Clin Microbiol Infect Dis. 2020;39(6):1011-1019. https://doi.org/10.1007/s10096-020-03874-z.
36	36. Sifuentes-Rodríguez E, Palacios-Reyes D. COVID-19: the outbreak caused by a new coronavirus. Bol Med Hosp Infant Mex 2020;77(2):47-53. https://doi.org/10.24875/BMHIM.20000039
37	37. Baloch S, Baloch MA, Zheng T, Pei X. The Coronavirus Disease 2019 (COVID-19) Pandemic. Tohoku J Exp Med 2020 Apr;250(4):271-278. https://doi.org/10.1620/tjem.250.271
38	38. Steinberg E, Balakrishna A, Habboushe J, Shawl A, Lee J. Calculated Decisions: COVID-19 Calculators During Extreme Resource-Limited Situations. Emerg Med Pract 2020;22(4 Suppl):CD1- CD5. 39. Малхасян В.А., К
39	39. Малхасян В.А., Касян Г.Р., Ходырева Л.А., Колонтарев К.Б., Говоров А.В., Васильев А.О., Пушкарь Д.Ю. Оказание стационарнои помощи пациентам урологического профиля в ̆ условиях пандемии коронаровируснои инфекции ̆ COVID-19. Экспериментальная и клиническая урология 2020;(1):4-11. [Malkhasyan V.A., Kasyan G.R., Khodyreva L.A., Kolontarev K.B., Govorov A.V., Vasiliev A.O., Pushkar D.Yu. providing inpatient care to urological patients in the context of the COVID-19 coronarovirus pandemic. Eksperimental'naya i klinicheskaya urologiya = Experimental and Clinical urology 2020;(1):4- 11. (In Russian)]. https://doi.org/10.29188/2222- 8543-2020-12-1-4-1.
40	40. Stensland KD, Morgan TM, Moinzadeh A, Lee CT, Briganti A, Catto J, Canes D. Considerations in the triage of urologic surgeries during the COVID-19 pandemic. Eur Urol 2020;77(6):663‐666. https://doi.org/10.1016/j.eururo.2020.03.027.
41	41. Un contagio su dieci tra medici e infermieri, in trincea con mascherine inadatte e pochi tampon. [Электронный ресурс]. URL: https://www.ilsole24ore.com/art/ un-contagio-dieci- %0Amedicie infermieritrinceamascherine-inadattee-pochi-tamponi-ADqwiFF
42	42. EAU Robotic Urology Section (ERUS) guidelines during COVID-19 emergency. [Электронный ресурс]. URL: https://uroweb.org/eau-robotic-urology-section-erus-guide-lines-duringc..., accessed on March 29, 2020.
43	43. Ficarra V, Novara G, Abrate A, Bartoletti R, Crestani A, de Nunzio C, et al. Urology practice during COVID-19 pandemic. Minerva Uro
44	44. Hollander J, Car B. Virtually Perfect? Telemedicine for Covid-19. N Engl J Med 2020(382)1679- 168. https://doi.org/10.1056/NEJMp2003539
45	45. Moazzami B, Razavi-Khorasani N, Dooghaie Moghadam A, Farokhi E, Rezaei N. COVID-19 and telemedicine: immediate action required for maintaining healthcare providers well-being. J Clin Virol 2020(126):104345. [Электронный ресурс]. URL: https://www.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd4029942. https://doi.org/10.1016/j.jcv.2020.10434513.
46	46. Для цитирования: Деревянко Т.И., Придчин С.В. Геморрагический инфаркт яичка как осложнение COVID-19 (SARS-CoV-2). Экспериментальная и клиническая урология 2021;14(2):70-72; https://doi.org/10.29188/2222-8543-2021-14-2-70-72.
47	47. А.Г. Алиев, А. Риахи, А.П. Середа, Е.В. Вебер, И.И. Шубняков, Р.М. Тихилов. Влияние пандемии Сovid-19 на госпитализацию пациентов после артропластики коленного и тазобедренного суставов. https://doi.org/10.18019/1028-4427-2021-27-5-570-577.